Dutch SME building portable microfluidic biosensors for on-site food quality and environmental contamination detection.
INNOSIEVE DIAGNOSTICS BV is a Dutch diagnostics technology SME that designs and builds miniaturized biosensor systems capable of bringing laboratory-grade analysis into real-world field and industrial environments. Their technical core combines microfluidics, nanoplasmonics, and optical bio-recognition to create compact, portable detection platforms. In H2020 consortia, they serve as the sensing hardware specialists — developing the physical detection layer that makes complex chemical or biological measurements feasible outside a lab. Their work spans food safety monitoring and environmental contamination detection, demonstrating a platform approach where the same core sensing technology is adapted to different application domains.
Both h-ALO and PlasticsFatE rely on INNOSIEVE's core biosensor and detection competencies, with h-ALO explicitly centered on photonic system integration, nanoplasmonics, and bio-recognition.
h-ALO lists microfluidics, system integration, and miniaturization as defining keywords, pointing to INNOSIEVE's role in building the fluidic architecture of the sensing device.
h-ALO targets on-site, multi-analyte food-chain monitoring, with portability and on-site demonstration as explicit project goals.
PlasticsFatE focuses on fate, exposure, and hazard of micro- and nano-plastics in the human body and environment, where INNOSIEVE likely contributes analytical or sensing capabilities.
Both H2020 projects began in 2021, so the keyword shift does not reflect chronological development but rather parallel application domains pursued simultaneously. The first project (h-ALO) anchors INNOSIEVE in their established technical territory — photonic biosensors, microfluidics, optical bio-recognition — applied to food quality. The second project (PlasticsFatE) extends the same detection logic toward environmental and human health risk assessment for nanoplastics, a domain where robust miniaturized sensing is urgently needed. The net picture is a company broadening its addressable market by adapting a proven sensing platform to new regulatory and societal concerns rather than pivoting away from its roots.
INNOSIEVE appears to be positioning its portable microfluidic biosensor platform as a horizontal technology applicable wherever fast, field-deployable chemical detection is needed — a trajectory pointing toward environmental monitoring, food safety regulation, and potentially point-of-care diagnostics.
INNOSIEVE participates exclusively as a consortium partner and has not led any H2020 project, which is typical for a specialized technology SME contributing a defined hardware or sensing component to larger research programs. With 34 unique partners across just 2 projects, they operate within large, multi-partner consortia averaging roughly 17 partners each — indicating they are comfortable in complex, distributed research environments. This profile suggests they work best as a focused contributor delivering a specific technical module rather than as a coordination or project management hub.
INNOSIEVE has built connections with 34 unique consortium partners across 13 countries through only 2 projects, reflecting the large RIA consortia they join. Their network spans Europe broadly, as is standard for Horizon 2020 Research and Innovation Actions.
INNOSIEVE occupies a specific niche that few SMEs fill: they combine nanoplasmonics and microfluidics with a clear application focus on portability and on-site deployment, bridging the gap between academic photonics research and practically usable diagnostic devices. As an SME rather than a university group, they bring manufacturing sensibility and integration discipline that helps consortia move from lab prototype toward demonstrable systems. For a consortium builder, they represent an industry voice with genuine hardware depth rather than a token commercial partner.
